Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,959.20
(
-0.23%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.67
(
2.41%
)
Bitcoin
73,648.76
(
-1.60%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rwdm

Send PM Follow Ignore
Followers 1
Posts 132
Boards Moderated 0
Alias Born 07/19/2010

rwdm

Re: DewDiligence post# 99877

Tuesday, 07/27/2010 4:34:46 PM

Tuesday, July 27, 2010 4:34:46 PM

Post# of 257250
Can you imagine that FDA's demand for a complicated molecule such as Copaxone would be less (without bioequivalence) than for a simple compound such as aspirin?
Thanks for your welcoming.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now